Psychosocial Effects and Panic Regarding Corona Virus

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1689-1694
Author(s):  
Amir Ali

After the hike of the Coronavirus from the country of China in the end of the previous year, Novel Coronavirus accounts for a total of about 46 million cases all around the world with the death of more than 1.28 million individuals & 31.8 million recoveries. Besides its extraordinary infectivity & casualty rates, Corona Virus Disease has caused widespread panic, economic weight & budgetary misfortunes. Mass terror of CORONA VIRUS, named as "corona phobia", has made an adequate mental indications in over-all population. Along these lines, this audit has been embraced to characterize panic consequence of CORONA Virus. The quarantine can create extreme anger, nervousness, accumulating, psychological illness & sadness. Strengthened through an "infodemic" extent through a various foundation in web-based broadcasting. Upheavals bigotry, defamation, & tolerance against specific networks remain additionally being broadly detailed. All things considered, bleeding-edge medical services laborers are at higher danger of getting the illness just as encountering unfriendly mental results in a type of burnout, tension, fear of communicating contamination, a sentiment of contrariness, wretchedness, & extended substance-reliance. Network-based alleviation projects to battle coronavirus will upset youngster normal way of life & may cause flowery psychological depression. Networks remain pretentious by disease in several manners & want exceptional consideration. 

2020 ◽  
pp. 46-55

A new major epidemic foci of corona virus disease 2019 known as COVID-19, previously known as 2019-nCoV have been identified and rapidly expanding throughout the world without traceable origin since early 2020. The disease has drastically increased and the affected number of countries, states or territories reporting infection to WHO was more than 2001. The 2019 novel corona virus disease outbreak was instigated from Wuhan, Hubei province, China at late December 2019 and affirmed as a public health threat emerging of International anxiety on 30th January 2020 by WHO2. International Committee on Taxonomy of Viruses (ICTV) declared “Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV2)” as the name of novel corona virus, because their genetically similarities with SARS outbreak in 2003. The present review focuses on morphological, genetical characterization of SARS – CoV – 2 as well as the clinical traits and clinical therapies for COVID – 19 endemic up to date. The novel coronavirus emergence awaken the echoes of SARS-CoV pandemic in past decades. Yet, with having best technological advance, the exact medication is still a question. It might be a great lesson to the world to equip to deal with most recent emergent viruses in future. The current work will give a deep understanding of CoV -2 to researcher for the further studies.


2021 ◽  
Author(s):  
desna rura sarapang

The emergence of a new virus in the global world at the end of 2019, namely Corona Virus Disease 2019, brought tremendous excitement to all inhabitants of the earth. The emergence of this virus brings tremendous concern and fear to the world because the spread of this virus is quite fast, even the most frightening is that the risk of death of people exposed to this virus is very large. Indonesia itself, cannot avoid the impact of this Covid-19 case. As a form of efforts to prevent and minimize transmission of the virus, the Indonesian government has issued a social distancing / physical distancing recommendation. This situation also causes the interaction between communities to be very limited. This situation seems to be able to eliminate hospitality among the community. This paper aims to emphasize the importance of maintaining the value of Christian hospitality in society amid the Covid-19 pandemic.


Author(s):  
Jahnvi Garg ◽  
Ranjit S. Ambad ◽  
Nandkishor Bankar

Introduction: This article includes the effect of Corona virus disease on cancer patients and their healthcare facilities. The global pandemic mentioned around the world has impacted the most vulnerable group of patients- cancer. With the assistance of RT PCR tests and HRCT, oncologists and doctors have tried to provide treatment to Covid-19 patients. Cancer patients are more susceptible to Covid-19 than non-cancer or non-survivor patients, according to reports. To avoid the prevalence and infection of cancer victims, WHO has suggested staying at home and continuing their treatment through telemedicine unless the situation is critical for which they might require therapy and/or surgery. Covid-19 is here to stay so we should practice with utmost care and precaution.


Author(s):  
Gabriel B. Iwasokun

The corona virus disease, otherwise known as COVID-19, is an extremely communicable and pathogenic viral infection caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), which emerged in Wuhan, China in December 2019 and has spread to almost all the countries in the world. The transmission of the virus is through touching of the nose, eyes, or mouth by a finger that has been contaminated through droplets on a surface when a carrier sneezes or coughs. Since the existing fingerprint devices are predominantly contact based, it implies that they can aid in the transmission of the virus. This paper discusses the application of fingerprint devices in notable places with high rate of COVID-19 infection as well as the threats to fingerprint technologies and the countermeasures. The need to change focus and orientation towards contactless biometric technologies as sure solution to the fear and animosity expressed towards contact-based fingerprint technology is also expatiated.


Author(s):  
Р.А. Майер ◽  
Б.А. Бакиров ◽  
А.А. Набиева ◽  
Д.А. Кудлай

Введение. В последние 2 года серьезной проблемой для всего мирового сообщества стало распространение новой коронавирусной (CoV) инфекции COVID-19 (COrona VIrus Disease-2019). Ввиду сложившихся событий в лечении COVID-19 активно стали применяться новые молекулы и уже зарегистрированные лекарственные препараты, доказавшие свою эффективность при других заболеваниях. Цель исследования: оценить эффективность применения препарата экулизумаб у пациентов с тяжелой формой течения COVID-19. Материалы и методы. Проанализированы 3 клинических случая применения препарата экулизумаб в составе комплексной терапии у пациентов с тяжелой формой течения COVID-19. Для оценки эффективности лечения проводился мониторинг основных клинико-лабораторных показателей, а также показателей, характеризующих воспалительный процесс при коронавирусной инфекции: общий анализ крови, биохимический анализ крови, проанализированы уровни таких показателей как ферритин, С-реактивный белок, интерлейкин-6, лактатдегидрогеназа и мембраноатакующий комплекс. Результаты. На фоне проводимой терапии выявлено снижение концентрации основных маркеров воспаления относительно исходных значений. Заключение. Комплексная терапия, включающая экулизумаб, облегчает течение заболевания, позволяет сократить длительность пребывания пациентов в отделении реанимации и интенсивной терапии, укорачивает срок их пребывания на искусственной вентиляции легких, тем самым снижая процент летальности. Background. In the past two years, the incidence of the novel coronavirus (CoV) infection COVID-19 (COrona Virus Disease-2019) has been a serious problem for the global community. Considering these circumstances, new molecules and already registered drugs that have proven their effectiveness in other diseases, began to be actively used in COVID-19 treatment. Objectives: to assess the effi cacy of eculizumab in patients with severe COVID-19. Patients/Methods. Three clinical cases of eculizumab use as a part of complex therapy in patients with severe COVID-19 have been analyzed. To assess the treatment efficacy, the main clinical and laboratory parameters and indicators of inflammatory process in coronavirus infection were monitored (clinical blood analysis, biochemical blood test, levels of ferritin, C-reactive protein, interleukin-6, lactate dehydrogenase and membrane attack complex). Results. Under the therapy we found the reduction of concentration of the main inflammation markers relative to the initial values. Conclusions. Complex therapy with eculizumab facilitates the course of the disease, reduces the stay duration of patients in the intensive care unit, shortens the period of artificial lung ventilation, thereby reducing the mortality rate.


2021 ◽  
Vol 8 (38) ◽  
pp. 3401-3405
Author(s):  
Arunima Chaudhuri ◽  
Suhrita Paul ◽  
Tapas Ghosh

BACKGROUND The corona virus disease-19 (Covid-19) pandemic has put human civilization into a huge challenge, especially in the field of medicine in the management of patients with co-morbidities. Health authorities across the world depend greatly on reliable data to make major decisions and this is especially true during this global pandemic. The present review was conducted to estimate the challenges in the management of Covid-19 patients with metabolic syndrome with special emphasis on gender and age. Patients having pre-existing health conditions e.g., heart disease, diabetes are at higher risk of morbidity and mortality due to COVID-19. According to the WHO newsletter, COVID-19 has tragically claimed more than 1.5 million lives. The burden of obesity across the world has nearly tripled since 1975. In 2016, 1.9 billion adults, were overweight; 650 million were obese; 13 % of the world's adult population (11 % of males and 15 % of females) were obese in 2016. Obesity has been observed to be a high-risk factor for COVID-19 severity. Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) targets the angiotensinconverting enzyme 2 (ACE2) for cell entry and ACE2 is highly expressed in adipose tissue. This suggests an important role for the tissue in determining COVID-19 disease severity in obese individuals.1-2 There has been an increase in death from diabetes by 70 % globally between 2000 and 2019, and an 80 % rise in deaths among males has been observed. Metabolic syndrome comprises three or more of the following factors: increased waist circumference; hypertriglyceridemia; elevated blood pressure; reduced high-density lipoprotein cholesterol; hyperglycemia.1-2 Visceral fat is known to produce higher concentrations of proinflammatory cytokines. These are then released in the bloodstream. Release of proinflammatory markers in blood stream may cause auto-amplifying cytokine production (“cytokine storms”) and low-grade inflammation. Cytokine storm and low-grade inflammation can contribute to worsening of COVID-19 patients with obesity. Components of metabolic syndrome such as hypertension, type 2 diabetes mellitus (T2DM), and obesity are highly prevalent among the general population and have been observed to significantly increase the risk of hospitalization and mortality in COVID-19 patients.1-2 KEYWORDS Covid-19 Pandemic, Metabolic syndrome, Aging, Gender


2020 ◽  
Vol 1 (2) ◽  
pp. 131-143
Author(s):  
Rif’at Ayu Wijdan Irham ◽  
A. Khawarizmi Siregar ◽  
Hasse Jubba

This paper aims to see how the response of Muslims and the government related to the Covid-19 pandemic that occurred throughout the world. This research is a qualitative study of document studies using sources consisting of publications. Muslims believe in this pandemic originating from Allah SWT, but Muslims are expected not to react to it too much and make this phenomenon to increase the capital of God for the Almighty God, Islamic jurisprudence can help find solutions to overcome it. Covid-19 Pandemic. The government as a leader in this country has implemented a policy related to the reduction of Covid-19. Many people who respond to the policies set by the government do not believe also because they oppose the government because of the lack of education by the government and Indonesian religious leaders.


Author(s):  
Mahmuda Yeasmin ◽  
Jannatut Tasnim ◽  
Arifa Akram ◽  
Md Abdullah Yusuf ◽  
AKM Shamsuzzaman ◽  
...  

Background: In December 2019, a novel corona virus (SARS-CoV-2) causes atypical pneumonia now known as “corona virus disease 2019” (COVID-19) emerged in Wuhan, China and spread rapidly throughout the world. Objective: The purpose of the present study was to identify the different plausible routes of transmission of SARS-CoV-2 into the human body. Methodology: We searched electronic databases (MEDLINE, EMBASE, Science Citation Index and Chinese database) checked documents and references. We included all the studies regarding potential routes of transmission of SARS-CoV-2. All reviewers independently screened titles and abstracts, assessed studies for inclusion, appraised quality, and extracted data. Result: SARS-CoV-2 has been found to have higher level of transmissibility than other two pathogenic CoVs. Sustained human to human transmission of SARS-CoV-2 has already been established though the exact route of transmission is yet to be determined. Similar to other CoVs, respiratory droplet and contact with contaminated surfaces are considered as principle route of transmission of SARS-CoV-2 whereas aerosol, feco-oral, perinatal, ocular surface and transfusion transmissions are the plausible route of spreading of this highly pathogenic CoVs. Conclusion: In the current review, we summarize the potential route of transmission of SARS-CoV-2 in the light of previous SARS-CoV and MERS-CoV outbreaks to solidify the scientific basis on which important decisions can be made. Bangladesh Journal of Infectious Diseases, April 2020;7(suppl_1):S18-S31


2020 ◽  
pp. 10.1212/CPJ.0000000000000882 ◽  
Author(s):  
Christopher G. Tarolli ◽  
Julia M. Biernot ◽  
Peter D. Creigh ◽  
Emile Moukheiber ◽  
Rachel Marie E. Salas ◽  
...  

Neurologists around the country and the world are rapidly transitioning from traditional in-person visits to remote neurologic care because of the corona virus disease 2019 pandemic. Given calls and mandates for social distancing, most clinics have shuttered or are only conducting urgent and emergent visits. As a result, many neurologists are turning to teleneurology with real-time remote video-based visits with patients, to provide ongoing care. Although telemedicine utilization and comfort has grown for many acute and ambulatory neurologic conditions in the past decade, remote visits and workflows remain foreign to many patients and neurologists. Here, we provide a practical framework for clinicians to orient themselves to the remote neurologic assessment, offering suggestions for clinician and patient preparation prior to the visit; recommendations to manage common challenges with remote neurologic care; modifications to the neurologic exam for remote performance, including subspecialty-specific considerations for a variety of neurologic conditions; and a discussion of the key limitations of remote visits. These recommendations are intended to serve as a guide for immediate implementation as neurologists transition to remote care. These will be relevant not only for practice today, but also for the likely sustained expansion of teleneurology following the pandemic.


Sign in / Sign up

Export Citation Format

Share Document